Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00135109
Show Display Options
Rank Status Study
1 Completed Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy
Condition: Diabetic Neuropathies
Intervention: Drug: SPM 927

Indicates status has not been verified in more than two years